djohn, The BOD and mgmt can change the direction and the fortunes of this company in one second if they really wanted to. Again, all it takes is an announcement of a qualified and real COB not one of ES's cronies. There is absolutely no harm that can be done in doing so and by not doing so mgmt is showing no matter what Mr. King says that they are not interested in accelerating their drug pipeline or making their company successful. Just think if the stock price was higher or if PPHM was sold how much faster the trials could be started and finished and how many more trials could be done. Instead they insult shareholders and make the pro mgmt supporters look even more dumber by saying the company is better off without a COB. (How has it gone so far without one?) Seven years and counting and not one person has been replaced on the board given all the mistakes they have made. Really criminal imo.
I got your point djohn. It doesn't make any difference if you are an analyst a blogger, or just an investor. All anyone has to do is look at the filings and press releases. Everything points to increased spending with no increase in revenue.
News 
Market Data 
Discover 
AI
